HLX vs CLOV vs OII vs TDW vs TPVG

For growth investors, Clover Health Investments, Corp.

(CLOV) is the stronger pick with 40. 3% revenue growth year-over-year, versus -4. 9% for Helix Energy Solutions Group, Inc. (HLX). TriplePoint Venture Growth BDC Corp. (TPVG) offers the better valuation at 4. 8x trailing P/E (6. 3x forward), making it the more compelling value choice. Analysts rate Helix Energy Solutions Group, Inc. (HLX) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, TriplePoint Venture Growth BDC Corp.

(TPVG) is the cheapest at 4. 8x versus Helix Energy Solutions Group, Inc. at 47. 9x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Helix Energy Solutions Group, Inc. wins at 3. 59x versus TriplePoint Venture Growth BDC Corp. 's 6. 20x.

Over the past 5 years, Tidewater Inc.

(TDW) delivered a total return of +460. 2%, compared to -49. 1% for Clover Health Investments, Corp. (CLOV). Over 10 years, the gap is even starker: TPVG returned +96. 0% versus CLOV's -66. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), TriplePoint Venture Growth BDC Corp.

(TPVG) is the lower-risk stock at 0. 70β versus Clover Health Investments, Corp. 's 1. 36β — meaning CLOV is approximately 95% more volatile than TPVG relative to the S&P 500. On balance sheet safety, Helix Energy Solutions Group, Inc. (HLX) carries a lower debt/equity ratio of 40% versus 133% for TriplePoint Venture Growth BDC Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Clover Health Investments, Corp.

(CLOV) is pulling ahead at 40. 3% versus -4. 9% for Helix Energy Solutions Group, Inc. (HLX). On earnings-per-share growth, the picture is similar: Oceaneering International, Inc. grew EPS 142. 4% year-over-year, compared to -93. 6% for Clover Health Investments, Corp.. Over a 3-year CAGR, TDW leads at 27. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

TriplePoint Venture Growth BDC Corp.

(TPVG) is the more profitable company, earning 50. 6% net margin versus -4. 4% for Clover Health Investments, Corp. — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus -4. 4% for CLOV. At the gross margin level — before operating expenses — TPVG leads at 83. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Helix Energy Solutions Group, Inc. (HLX) is the more undervalued stock at a PEG of 3. 59x versus TriplePoint Venture Growth BDC Corp. 's 6. 20x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, TriplePoint Venture Growth BDC Corp. (TPVG) trades at 6. 3x forward P/E versus 89. 7x for Clover Health Investments, Corp. — 83. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TPVG: 53. 0% to $8. 95.

In this comparison, TPVG (17.

5% yield) pays a dividend. HLX, CLOV, OII, TDW do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, TriplePoint Venture Growth BDC Corp.

(TPVG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 17. 5% yield). Both have compounded well over 10 years (TPVG: +96. 0%, CLOV: -66. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HLX (Energy) and CLOV (Healthcare) and OII (Energy) and TDW (Energy) and TPVG (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HLX is a small-cap quality compounder stock; CLOV is a small-cap high-growth stock; OII is a small-cap deep-value stock; TDW is a small-cap deep-value stock; TPVG is a small-cap high-growth stock. TPVG pays a dividend while HLX, CLOV, OII, TDW do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.